Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2/3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of MK-7655A in Pediatric Participants From Birth to Less Than 18 Years of Age With Confirmed or Suspected Gram-negative Bacterial Infection

Next Previous
Search
Trial Profile

A Phase 2/3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of MK-7655A in Pediatric Participants From Birth to Less Than 18 Years of Age With Confirmed or Suspected Gram-negative Bacterial Infection

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 30 Aug 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cilastatin/imipenem/relebactam (Primary) ; Amoxicillin; Amoxicillin/clavulanic acid; Antibacterials; Antibacterials; Cefaclor; Cefepime; Cefixime; Cefotaxime; Cefoxitin; Cefpodoxime proxetil; Ceftazidime; Ceftibuten; Ceftriaxone; Cefuroxime; Cefuroxime axetil; Ciprofloxacin; Ciprofloxacin; Cotrimoxazole; Delafloxacin; Gentamicin; Gentamicin; Imipenem/cilastatin; Levofloxacin; Levofloxacin; Meropenem; Metronidazole; Metronidazole; Moxifloxacin; Nitrofurans; Nitrofurantoin; Norfloxacin; Ofloxacin; Piperacillin/tazobactam; Sulfamethoxazole; Trimethoprim
  • Indications Gram-negative infections; Intra-abdominal infections; Nosocomial pneumonia; Urinary tract infections; Ventilator associated pneumonia
  • Focus Adverse reactions; Registrational
  • Sponsors Merck Sharp & Dohme Corp.

    • Most Recent Events

    • 03 Jul 2024 This study has been Completed in Bulgaria, According to European Clinical Trials Database record.
    • 27 May 2024 Status changed from active, no longer recruiting to completed.
    • 21 May 2024 This study has been Completed in Estonia, According to European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top